Literature DB >> 18606082

What causes itch in atopic dermatitis?

Gil Yosipovitch1, Alexandru D P Papoiu.   

Abstract

Itch, the hallmark of atopic dermatitis, has a significant impact on quality of life for patients with this disease. Various central and peripheral mediators have been suggested to play a role in the pathophysiology of atopic eczema itch. Significant cross-talk occurs among stratum corneum, keratinocytes, immune cells, and nerve fibers, which are in close proximity to one another and induce itch. The impaired barrier function associated with the itch-scratch cycle further augments this vicious cycle. Recent advances in our understanding of itch pathophysiology shed light on peripheral and central neural sensitization of nerve fibers that contribute significantly to itch in atopic dermatitis. Recently, several new mediators have been described as associated with itch in atopic dermatitis, including serine proteases, interleukin 31, and nerve growth factor. This review covers the peripheral and central mechanisms and mediators involved in pathogenesis of itch in atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18606082     DOI: 10.1007/s11882-008-0049-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity.

Authors:  Jean-Pierre Hachem; Mao-Quiang Man; Debra Crumrine; Yoshikazu Uchida; Barbara E Brown; Vera Rogiers; Diane Roseeuw; Kenneth R Feingold; Peter M Elias
Journal:  J Invest Dermatol       Date:  2005-09       Impact factor: 8.551

2.  Treatment of pruritus with topically applied opiate receptor antagonist.

Authors:  Paul L Bigliardi; Holger Stammer; Gerhard Jost; Theo Rufli; Stanislaw Büchner; Mei Bigliardi-Qi
Journal:  J Am Acad Dermatol       Date:  2007-02-22       Impact factor: 11.527

3.  Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature.

Authors:  G Yosipovitch; G L Xiong; E Haus; L Sackett-Lundeen; I Ashkenazi; H I Maibach
Journal:  J Invest Dermatol       Date:  1998-01       Impact factor: 8.551

4.  Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch.

Authors:  Miwa Hosogi; Martin Schmelz; Yoshiki Miyachi; Akihiko Ikoma
Journal:  Pain       Date:  2006-07-13       Impact factor: 6.961

Review 5.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

Authors:  Martin Steinhoff; John Bienenstock; Martin Schmelz; Marcus Maurer; Ed Wei; Tamás Bíró
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

Review 6.  Itch.

Authors:  Gil Yosipovitch; Malcolm W Greaves; Martin Schmelz
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

7.  The brain processing of scratching.

Authors:  Gil Yosipovitch; Yozo Ishiuji; Tejesh S Patel; Maria Isabel Hicks; Yoshitetsu Oshiro; Robert A Kraft; Erica Winnicki; Robert C Coghill
Journal:  J Invest Dermatol       Date:  2008-01-31       Impact factor: 8.551

Review 8.  Nocturnal itch: why do we itch at night?

Authors:  Tejesh Patel; Yozo Ishiuji; Gil Yosipovitch
Journal:  Acta Derm Venereol       Date:  2007       Impact factor: 4.437

9.  Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice.

Authors:  Sanja Pavlovic; Maria Daniltchenko; Desmond J Tobin; Evelin Hagen; Stephen P Hunt; Burghard F Klapp; Petra C Arck; Eva M J Peters
Journal:  J Invest Dermatol       Date:  2007-10-04       Impact factor: 8.551

10.  Possible roles of epidermal opioid systems in pruritus of atopic dermatitis.

Authors:  Mitsutoshi Tominaga; Hideoki Ogawa; Kenji Takamori
Journal:  J Invest Dermatol       Date:  2007-07-05       Impact factor: 8.551

View more
  38 in total

1.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

Review 2.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

3.  A subpopulation of itch-sensing neurons marked by Ret and somatostatin expression.

Authors:  Kalina K Stantcheva; Loredana Iovino; Rahul Dhandapani; Concepcion Martinez; Laura Castaldi; Linda Nocchi; Emerald Perlas; Carla Portulano; Martina Pesaresi; Kalyanee S Shirlekar; Fernanda de Castro Reis; Triantafillos Paparountas; Daniel Bilbao; Paul A Heppenstall
Journal:  EMBO Rep       Date:  2016-02-29       Impact factor: 8.807

4.  Redefinition of the human mast cell transcriptome by deep-CAGE sequencing.

Authors:  Efthymios Motakis; Sven Guhl; Yuri Ishizu; Masayoshi Itoh; Hideya Kawaji; Michiel de Hoon; Timo Lassmann; Piero Carninci; Yoshihide Hayashizaki; Torsten Zuberbier; Alistair R R Forrest; Magda Babina
Journal:  Blood       Date:  2014-03-26       Impact factor: 22.113

Review 5.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 6.  Therapy of pruritus.

Authors:  Tejesh Patel; Gil Yosipovitch
Journal:  Expert Opin Pharmacother       Date:  2010-07       Impact factor: 3.889

7.  Commiphora myrrha inhibits itch-associated histamine and IL-31 production in stimulated mast cells.

Authors:  Jae Young Shin; Denis Nchang Che; Byoung Ok Cho; Hyun Ju Kang; Jisu Kim; Seon Il Jang
Journal:  Exp Ther Med       Date:  2019-07-01       Impact factor: 2.447

Review 8.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

9.  Cowhage can induce itch in the atopic dog.

Authors:  Thierry Olivry; Petra Bizikova; Judy S Paps; Stan Dunston; Ethan A Lerner; Gil Yosipovitch
Journal:  Exp Dermatol       Date:  2013-06       Impact factor: 3.960

10.  Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease.

Authors:  Majedeline Belghiti; Judith Estévez-Herrera; Carla Giménez-Garzó; Alba González-Usano; Carmina Montoliu; Antonio Ferrer-Montiel; Vicente Felipo; Rosa Planells-Cases
Journal:  J Biol Chem       Date:  2013-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.